These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10815119)

  • 21. Association of C-reactive protein levels with fasting and postload glucose levels according to glucose tolerance status.
    Guerrero-Romero F; Simental-Mendía LE; Rodríguez-Morán M
    Arch Med Res; 2014 Jan; 45(1):70-5. PubMed ID: 24326321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.
    Stamler J; Stamler R; Neaton JD; Wentworth D; Daviglus ML; Garside D; Dyer AR; Liu K; Greenland P
    JAMA; 1999 Dec; 282(21):2012-8. PubMed ID: 10591383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relations of Postload and Fasting Glucose With Incident Cardiovascular Disease and Mortality Late in Life: The Cardiovascular Health Study.
    Brutsaert EF; Shitole S; Biggs ML; Mukamal KJ; deBoer IH; Thacker EL; Barzilay JI; Djoussé L; Ix JH; Smith NL; Kaplan RC; Siscovick DS; Psaty BM; Kizer JR
    J Gerontol A Biol Sci Med Sci; 2016 Mar; 71(3):370-7. PubMed ID: 26314953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. One-hour glucose value as a long-term predictor of cardiovascular morbidity and mortality: the Malmö Preventive Project.
    Nielsen ML; Pareek M; Leósdóttir M; Eriksson KF; Nilsson PM; Olsen MH
    Eur J Endocrinol; 2018 Mar; 178(3):225-236. PubMed ID: 29259038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.
    de Vegt F; Dekker JM; Jager A; Hienkens E; Kostense PJ; Stehouwer CD; Nijpels G; Bouter LM; Heine RJ
    JAMA; 2001 Apr; 285(16):2109-13. PubMed ID: 11311100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men.
    Smith GD; Egger M; Shipley MJ; Marmot MG
    Am J Epidemiol; 1992 Nov; 136(9):1110-4. PubMed ID: 1462971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Factors relevant to newborn birth weight in pregnancy complicated with abnormal glucose metabolism].
    Yang YD; Zhai GR; Yang HX
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):646-51. PubMed ID: 21092542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin use and pancreatic cancer mortality in a large United States cohort.
    Jacobs EJ; Connell CJ; Rodriguez C; Patel AV; Calle EE; Thun MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):524-8. PubMed ID: 15069114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.
    Kramer CK; von Mühlen D; Jassal SK; Barrett-Connor E
    J Intern Med; 2010 Jun; 267(6):561-6. PubMed ID: 20337857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.
    Bostom AG; Cupples LA; Jenner JL; Ordovas JM; Seman LJ; Wilson PW; Schaefer EJ; Castelli WP
    JAMA; 1996 Aug; 276(7):544-8. PubMed ID: 8709403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal fasting plasma glucose levels and type 2 diabetes in young men.
    Tirosh A; Shai I; Tekes-Manova D; Israeli E; Pereg D; Shochat T; Kochba I; Rudich A;
    N Engl J Med; 2005 Oct; 353(14):1454-62. PubMed ID: 16207847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active and passive smoking and risk of death from pancreatic cancer: findings from the Japan Collaborative Cohort Study.
    Lin Y; Yagyu K; Ueda J; Kurosawa M; Tamakoshi A; Kikuchi S;
    Pancreatology; 2013; 13(3):279-84. PubMed ID: 23719601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study.
    Snijder MB; Dekker JM; Visser M; Bouter LM; Stehouwer CD; Yudkin JS; Heine RJ; Nijpels G; Seidell JC;
    Diabetes Care; 2004 Feb; 27(2):372-7. PubMed ID: 14747216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.
    Miyake T; Hirooka M; Yoshida O; Furukawa S; Kumagi T; Koizumi M; Yamamoto S; Kuroda T; Arimitsu E; Takeshita E; Abe M; Kitai K; Matsuura B; Hiasa Y
    J Gastroenterol; 2017 Feb; 52(2):237-244. PubMed ID: 27342127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes.
    Chou P; Li CL; Wu GS; Tsai ST
    Diabetes Care; 1998 Jul; 21(7):1183-7. PubMed ID: 9653617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking and other risk factors for pancreatic cancer: a cohort study in men in Lithuania.
    Kuzmickiene I; Everatt R; Virviciute D; Tamosiunas A; Radisauskas R; Reklaitiene R; Milinaviciene E
    Cancer Epidemiol; 2013 Apr; 37(2):133-9. PubMed ID: 23107757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
    Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
    Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance.
    Rattarasarn C; Leelawattana R; Soonthornpun S
    Metabolism; 2010 Feb; 59(2):172-6. PubMed ID: 19765781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.
    Patel AV; Rodriguez C; Bernstein L; Chao A; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):459-66. PubMed ID: 15734973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project.
    Johansen D; Stocks T; Jonsson H; Lindkvist B; Björge T; Concin H; Almquist M; Häggström C; Engeland A; Ulmer H; Hallmans G; Selmer R; Nagel G; Tretli S; Stattin P; Manjer J
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2307-17. PubMed ID: 20826833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.